… –elevation myocardial infarction is associated with an intense acute inflammatory response
and risk of heart failure. We tested whether interleukin‐1 … –elevation myocardial infarction (…

… evaluate interleukin-1 receptor antagonist (IL-1Ra) levels in patients with ST-segment elevation
acute myocardial infarction … by comparison with common markers of myocardial necrosis. …

… Interleukin 1β (IL-1β) is a key regulator of the inflammatory response after myocardial infarction
(MI) … Elevated levels of IL-1β are associated with adverse remodeling, and inhibition of IL-…

… Interleukin-1Ra may also represent a useful diagnostic tool in patients with acute
myocardial infarction (MI), since its levels rise early and precede release of markers of myocardial …

… with ST elevation myocardial infarction (STEMI) and portends a poor prognosis. Interleukin
1-β … (recombinant human interleukin-1 [IL-1] receptor antagonist) suppresses leukocytosis in …

… of 10 patients with acute myocardial infarction with ST-segment elevation (STEMI), Anakinra
… of symptoms appeared to have beneficial effects on cardiac remodelling [1]. However, in the …

… ST-segment elevation myocardial infarction (STEMI) is associated with an intense acute …
In this study, we sought to evaluate the effect of anakinra, a recombinant interleukin-1 …

… non-ST-segment elevation myocardial infarction (NSTEMI), IL-1 blockade with anakinra also
reduced CRP levels at 7 days after non-ST-segment elevation acute coronary syndrome but …

… In conclusion, interleukin-1 blockade with anakinra blunted … ST-segment elevation acute
myocardial infarction. Although it … Acute myocardial infarction with ST-segment elevation (STEMI…

… elevation myocardial infarction (STEMI5, 6), non–ST-segment elevation myocardial infarction
(… , 11 It is, however, unknown whether IL-1 activity is a modifiable factor leading to improved …